Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Walleye Capital's IONS Position: Q3 2026 in Review
Walleye Capital increased its Ionis Pharmaceuticals (IONS) stake by 4,551,400% in Q3 2026, buying an estimated $5.17M and bringing the position to 91,030 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2113.
Walleye Capital first reported a position in IONS in Q1 2019 and has held it in 17 quarters since. The position peaked at $4.97M in Q3 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Walleye Capital held 91,030 shares of Ionis Pharmaceuticals worth $4.06M as of Q3 2026.
- Walleye Capital bought 91,028 Ionis Pharmaceuticals shares in Q3 2026, an estimated $5.17M.
- Ionis Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2113 holding.
- Walleye Capital first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
- Walleye Capital's Ionis Pharmaceuticals position peaked at $4.97M in Q3 2024.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.